Alonso Salinas, Gonzalo Luis

Profile Picture

Email Address

person.page.identifierURI

https://academica-e.unavarra.es/handle/2454/48508

Birth Date

Job Title

Last Name

Alonso Salinas

First Name

Gonzalo Luis

person.page.departamento

Ciencias de la Salud

person.page.instituteName

ORCID

0000-0001-5914-8526

person.page.observainves

1174654

person.page.upna

812576

Name

Filters

20242
Reset filters

Settings

Has files: true × Subject: Acute coronary syndrome ×

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    PublicationOpen Access
    Accuracy of smartwatch electrocardiographic recording in the acute coronary syndrome setting: rationale and design of the ACS WATCH II Study
    (MDPI, 2024) Buelga Suárez, Mauro; Pascual Izco, Marina; García Montalvo, Jesús; Alonso Salinas, Gonzalo Luis; Ciencias de la Salud; Osasun Zientziak
    Background: Acute Coronary Syndrome (ACS), with or without ST-segment elevation, is a major contributor to global mortality and morbidity. Swift diagnosis and treatment are vital for mitigating cardiac damage and improving long-term outcomes. The 12-lead electrocardiogram (ECG) currently serves as the gold standard for diagnosis in ACS with ST-segment elevation and may support the diagnosis in ACS without ST-segment elevation. However, the growing prevalence of smartwatches enables the acquisition of electrocardiographic data without traditional ECG equipment. While smaller studies support smartwatch ECG use, larger-scale validation within ACS remains lacking. The ACS WATCH II study aims to validate smartwatch ECG recordings for ACS. Methods: The primary objective is to validate smartwatch-obtained electrocardiographic data in patients presenting with ACS. Two cohorts of 120 patients each, presenting ACS with and without ST-segment elevation, will be assessed. Smartwatches will capture recordings of leads I, III, and V2 alongside standard ECGs. These leads, chosen due to a 97% ACS diagnosis sensitivity in previous studies, will undergo blind evaluation by two experienced external assessors against conventional ECG. Additionally, a control sample of 60 healthy individuals will be included. Conclusions: ACS WATCH II pioneers large-scale prospective validation of smartwatch ECG recordings in ACS patients. Additionally, it indirectly validates a swift diagnostic approach using three leads (I, III, and V2). This could expedite time-critical ACS diagnoses and simplify access through smartwatch-based diagnosis.
  • Thumbnail Image
    PublicationOpen Access
    The impact of geriatric conditions in elderly patients with coronary heart disease: a state-of-the-art review
    (MDPI, 2024) Alonso Salinas, Gonzalo Luis; Cepas-Guillén, Pedro; Martínez León, Amaia; Jiménez-Méndez, César; Lozano Vicario, Lucía; Martínez-Avial, María; Díez-Villanueva, Pablo; Ciencias de la Salud; Osasun Zientziak
    The growing geriatric population presenting with coronary artery disease poses a primary challenge for healthcare services. This is a highly heterogeneous population, often underrepresented in studies and clinical trials, with distinctive characteristics that render them particularly vulnerable to standard management/approaches. In this review, we aim to summarize the available evidence on the treatment of acute coronary syndrome in the elderly. Additionally, we contextualize frailty, comorbidity, sarcopenia, and cognitive impairment, common in these patients, within the realm of coronary artery disease, proposing strategies for each case that may assist in therapeutic approaches.